Outcomes with Avelumab Maintenance Treatment for Advanced Urothelial Cancer in a US Patient Cohort.

Carson K, Mahmoudpour SH, Ike C, Monzon S, Fragkogianni S, Kearney M

Open source

DOI
10.3390/curroncol33030138
Published
2026 Feb 27
Container
Current oncology (Toronto, Ont.)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/curroncol33030138,
  title = {Outcomes with Avelumab Maintenance Treatment for Advanced Urothelial Cancer in a US Patient Cohort.},
  author = {Carson K and Mahmoudpour SH and Ike C and Monzon S and Fragkogianni S and Kearney M},
  year = {2026},
  journal = {Current oncology (Toronto, Ont.)},
  doi = {10.3390/curroncol33030138},
  url = {https://doi.org/10.3390/curroncol33030138}
}

RIS

TY  - JOUR
TI  - Outcomes with Avelumab Maintenance Treatment for Advanced Urothelial Cancer in a US Patient Cohort.
AU  - Carson K
AU  - Mahmoudpour SH
AU  - Ike C
AU  - Monzon S
AU  - Fragkogianni S
AU  - Kearney M
PY  - 2026
JO  - Current oncology (Toronto, Ont.)
DO  - 10.3390/curroncol33030138
UR  - https://doi.org/10.3390/curroncol33030138
ER  - 

APA

K, C., SH, M., C, I., S, M., S, F., & M, K. (2026). Outcomes with Avelumab Maintenance Treatment for Advanced Urothelial Cancer in a US Patient Cohort.. Current oncology (Toronto, Ont.). https://doi.org/10.3390/curroncol33030138

Source records